Skip to content

SION SION Total Current Assets

Total Current Assets at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$11.73B+17.2%
AbbVie logo
AbbVieABBV
$33.53B+21.2%
Septerna, Inc. logo
Septerna, Inc.SEPN
$368.06M+7.5%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$373.63M-8.9%
Denali Therapeutics Inc. logo
Denali Therapeutics Inc.DNLI
$1.02B+16.4%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$2.44B+48.7%

Other financials

Income statement

See full
Operating income-$29.6M-50.6%
Net income-$26.8M-62.5%
EPS (diluted)-$0.60+3.2%

Balance sheet

See full
Cash & equivalents$64.3M-23.2%
Total debt$8.4M-11.8%
Total equity$288.2M-18.1%
Total assets$305.0M-17.5%

Cash flow

See full
Operating cash flow-$21.8M-34.1%
CapEx--100%
Free cash flow-$21.8M-33.4%

Valuation

See full
Market cap$1.86B

Returns & leverage

See full
Return on equity-26.7%
Debt / equity0.0×
Current ratio22.6×-6.1×

Where this comes from

Reported directly by SION in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The official record: SION’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SION's total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SION's total current assets?
SION (SION) reported total current assets of $220.96M in Q1 2026.
How has SION's total current assets changed year-over-year?
SION's total current assets decreased by 19.3% year-over-year, from $273.68M to $220.96M.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.